Symptoms of Cerebral Amyloid Angiopathy
Cerebral amyloid angiopathy (CAA) most commonly presents with lobar intracerebral hemorrhage in elderly patients, but also causes cognitive decline, transient focal neurological episodes, and can remain asymptomatic until serious complications occur.
Primary Clinical Manifestations
Hemorrhagic Presentations
Lobar intracerebral hemorrhage is the most serious and common symptomatic manifestation of CAA, typically occurring in the frontal, parietal, temporal, or occipital lobes 1. These hemorrhages carry a high risk of recurrence, with CAA having among the highest recurrence rates of all stroke subtypes 2.
- Cortical superficial siderosis (cSS) results from blood leakage into the subarachnoid space and is an important predictor of future hemorrhage 1.
- Cortical subarachnoid hemorrhage (cSAH) can occur and also predicts increased risk of recurrent intracerebral hemorrhage 2.
- Cerebral microbleeds appear as small hemorrhagic lesions on MRI, predominantly in lobar locations, and often occur without clinically apparent symptoms 1. Studies show that 12% of memory clinic patients developed incident microbleeds over 1.9 years of follow-up with no attributable clinical symptoms 1.
Transient Focal Neurological Episodes ("Amyloid Spells")
Patients experience episodic transient neurological deficits commonly misdiagnosed as seizures or transient ischemic attacks 3. These "amyloid spells" represent a distinct clinical feature of CAA and should raise diagnostic suspicion in elderly patients with appropriate imaging findings 3, 4.
Cognitive and Behavioral Symptoms
Progressive cognitive decline affecting multiple domains is a major manifestation of CAA, even in the absence of hemorrhage 2, 4.
- Dysexecutive syndrome can occur due to CAA's predilection for frontal lobe involvement 5.
- Dementia risk is particularly high after intracerebral hemorrhage in patients with CAA 2.
- CAA can mimic other dementia syndromes including logopenic variant primary progressive aphasia, normal pressure hydrocephalus, and Lewy body dementia 5.
- It is not established that microhemorrhages themselves cause neurological symptoms in the setting of Alzheimer's disease and presumed CAA 1.
Inflammatory Subtype
CAA-related inflammation presents with rapid cognitive decline and neurological deficits, requiring early recognition and prompt treatment for better functional outcomes 3, 4. This subtype represents a symptomatic immune response that can cause significant vascular damage 6, 7.
Asymptomatic and Preclinical Phase
CAA has a long preclinical phase starting decades before symptoms emerge 6, 7. Many patients remain asymptomatic despite significant amyloid deposition:
- The pathophysiology follows consecutive stages: amyloid-β deposition, decreased vascular reactivity, non-hemorrhagic changes, and ultimately hemorrhages 6.
- In hereditary CAA, the first signs are white matter lesions, cortical microinfarcts, and impaired occipital cerebral vasoreactivity 2.
Associated MRI Findings (Often Asymptomatic)
Beyond hemorrhagic lesions, CAA causes several imaging abnormalities that may not produce symptoms:
- White matter hyperintensities, particularly in frontal and parietal-occipital regions 1.
- Visible centrum semiovale perivascular spaces (severe) 8.
- Lobar-located lacunes 2.
- Cortical atrophy 2.
- White matter hyperintensities in a multispot pattern 8.
Clinical Pitfalls
Amyloid imaging cannot distinguish between vascular amyloid (CAA) and parenchymal plaques, and both are highly prevalent in elderly patients with or without dementia 1. Occasionally, CAA can occur without typical Alzheimer's pathology and still cause progressive dementia 1.
The presence of microbleeds does not reliably predict symptoms, as they frequently occur without clinical manifestations 1. However, they do identify patients at risk for the more serious complication of lobar hemorrhage 1.